InvestorsHub Logo
Followers 368
Posts 5763
Boards Moderated 0
Alias Born 07/18/2009

Re: None

Sunday, 06/12/2022 2:59:56 PM

Sunday, June 12, 2022 2:59:56 PM

Post# of 118383
OTCShotCaller
6/11/22, 06:54 PM

- Yup an we are about to enter into clinical trials on that Check Point Inhibitor NR2F6 any day. It could happen on Monday! Matter if it's this week or next, one way or another, it's going to happen soon! When that happens there will be an immediate fundamental shift in the valuation of this company that will push the pps upward. The fact that Dr. Koos has submitted the IND for NR2F6 to develop an mRNA vaccine for treating pancreatic and colon cancer, means he must have completed Pre-Clinical for that to happen for reason the results of Pre-Clinical are looked at closely before granting approval to proceed to Phase